anti-cancer drug

2 trials

Sponsors

Nagoya University Hospital

Conditions

Pancreatic cancergallbladder cancer

Phase 2

Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer

Active, not recruitingJPRN-UMIN000001267

Nagoya University Hospitalgallbladder cancer

Start: 2008-04-01Target: 20Updated: 2026-06-29

Unknown Phase

Assessment of tolerance and efficacy of 2nd line S-1 therapy after 1st line GEM for unresectable pancreatic cancer patients

Active, not recruitingJPRN-UMIN000000834

Nagoya University HospitalPancreatic cancer

Start: 2007-09-01Target: 14Updated: 2026-06-29